Narcolepsy Drug Market Global Size, Growth and Covid – 19 Pandemic Impact on Demand 2021 – 2030

The Global Narcolepsy Drug Market size was valued at USD 2.65 billion in 2019, and is predicted to reach USD 6.48 billion by 2030 with a CAGR of 8.4% from 2020-2030.

Narcolepsy is an orphan disease causing a long-term neurological disorder resulting into decreased ability in regulating sleep-wake cycles. The loss of brain-chemical called hypocretins (orexins) causes narcolepsy. Its symptoms are excessive daytime sleepiness, sleep attacks, disrupted night-time sleep, and in some cases, cataplexy, hallucinations, and/or sleep paralysis are observed.

Access Full Description of this report at:–

https://www.nextmsc.com/report/narcolepsy-drug-market

Top Companies: Teva Pharmaceutical Industries Ltd., Arena Pharmaceuticals, Shire Plc, Addrenex Pharmaceuticals, Jazz Pharmaceuticals Plc., Bioprojet, Ligand Pharmaceuticals, and Graymark Healthcare, Inc.

Market Dynamics and Trends

The global Narcolepsy drug market observes a substantial growth and is expected to grow at a considerable rate throughout the forecast period. Higher prevalence of sleep disorders resulting from high stress levels, unhealthy lifestyles, as well as increased consumption of alcohol, coffee, and tobacco, are anticipated to supplement the growth of narcolepsy drug market.

Furthermore, factors such as advancements in healthcare infrastructures, ongoing R&D activities, and rise in per-capita disposable incomes, are expected to propel the growth of narcolepsy drug market throughout the forecast period.

According to Narcolepsy Network, 60% of patients were misdiagnosed of Narcolepsy, and only 25% people suffering from narcolepsy have been diagnosed and are undergoing proper treatment. Hence, the lack of awareness regarding proper diagnosis and treatment availability, are the limiting factors hampering the growth of global narcolepsy drug market.

Moreover, increase in initiatives by government and non-government organizations in spreading awareness about this rare disease, and favorable reimbursement policies for FDA-approved prescribed medicines, shall create lucrative opportunities in the global narcolepsy drug market.

Request sample copy of this report at:-

https://www.nextmsc.com/Narcolepsy-Drug-Market/request-sample

Market Segmentations and Scope of the Study:

The global narcolepsy drug market share has been analyzed based on disease type, diagnosis, drug type, and geography.

Based on disease type, the market is segmented into narcolepsy type I and narcolepsy type II. Based on diagnosis, the market is divided into Polysomnogram, and Multiple Sleep Latency Test. Based on the type of drug, the market is fragmented into Tricyclic Antidepressants, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America represents high prevalence rate of sleep disorders due to unhealthy lifestyles as well as increased consumption of alcohol and tobacco. Furthermore, the increase in research and development activities, constant increase in FDA approval of drugs, and developed healthcare infrastructure are supplementing the growth of the narcolepsy drug market.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to fast developing healthcare facilities in this region. Additionally, increasing awareness about sleep disorders, and growing adoption of narcolepsy drugs, are further expected to augment the growth of narcolepsy drug market over the forecast period.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.